Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unveiling the Germline Predisposition to Myeloproliferative Neoplasms

NCT07204392 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.

NCT NCT07204392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07204392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unveiling the Germline Predisposition to Myeloproliferative Neoplasms
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase
Observational
Overall status
Recruiting
Start date
June 27, 2022
Completion date
December 31, 2030
Enrollment
313 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

germline mutation, myeloproliferative disease